Outcomes II: Transforming Clinical Cases into Scientific Dialogue

We are pleased to announce the publication of Outcomes II, a new international collection of 45 clinical case reports that provide valuable insights into the use of Cerebrolysin® in everyday neurological practice.

Drawing on the experience of physicians from different countries, healthcare settings and patient care specifics, Outcomes II offers a broad representation of real-world clinical scenarios involving patients with stroke, traumatic brain injury and other neurological conditions. The cases illustrate which treatment strategies are applied in individual patients and showcase the diversity of clinical realities.

While individual case reports cannot replace evidence from randomized clinical trials, they play an important complementary role. They provide a window into daily clinical practice, highlighting therapeutic decision-making, patient characteristics, treatment timing and recovery trajectories.

We hope that this international compilation will stimulate professional exchange, support clinical learning and contribute to ongoing efforts to improve outcomes for patients affected by neurological injury. Through shared experience and clinical dialogue, Outcomes II aims to advance our understanding which patients are most likely to benefit from cerebroprotective treatment and how to optimize their rehabilitation journey.